ArticleJournal of nanobiotechnology2026
A sequentially targeted and pathology-responsive nanoplatform for synergistic treatment of dry eye disease via concurrent anti-inflammation and mitochondrial ROS scavenging.
Liandi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.